(redirected from adenocarcinoma of the prostate)
Also found in: Dictionary, Medical, Acronyms, Encyclopedia, Wikipedia.
Related to adenocarcinoma of the prostate: Gleason scale
  • noun

Synonyms for adenocarcinoma

malignant tumor originating in glandular epithelium

References in periodicals archive ?
Adenocarcinoma of the prostate with aberrant expression of p63: a radical prostatectomy study.
Metastatic adenocarcinoma of the prostate as a cause of subdural hematoma.
Adenocarcinoma of the prostate with endometrioid features: a light microscopic and immunohistochemical study of ten cases.
Mucinous adenocarcinoma of the prostate is a rare morphological variant of prostatic adenocarcinoma, accounting for an incidence of about 0.
However, Medicare officials will not provide coverage for initial PET assessments of patients with adenocarcinoma of the prostate because the available evidence does not show that these would improve physician decision making.
We describe two elderly male patients with adenocarcinoma of the prostate and secondary pleural effusion.
Adenocarcinoma of the prostate is dependent on androgen for tumour progression and depleting or blocking androgen action has been a mainstay of hormonal treatment for over six decades.
Long-term results of an RTOG phase II Trial (00-19) of external-beam radiation therapy combined with permanent source brachytherapy for intermediate-risk clinically localized adenocarcinoma of the prostate.
Chromosomal imbalances, loss of heterozygosity, and immunohistochemical expression of TP53, RB1, and PTEN in intraductal cancer, intraepithelial neoplasia, and invasive adenocarcinoma of the prostate.
Baxter focused on patients with invasive, nonmetastatic, adenocarcinoma of the prostate who entered the registry during 1973-1994, a total of more than 85,000 men.
Men aged 18 years and older with histologically confirmed adenocarcinoma of the prostate are eligible.
Primary signet ring cell adenocarcinoma of the prostate.
It is important to be aware of this possibility to avoid misinterpretation as a high-grade signet ring adenocarcinoma of the prostate.
The 5[alpha]-reductase isoenzymes convert testosterone to the androgen dihydrotestosterone, a necessary step in the initiation and maintenance of adenocarcinoma of the prostate.
We identified all residents of Ontario, Canada who were diagnosed with adenocarcinoma of the prostate between 1990 and 1998 and were either curatively treated with radical prostatectomy or radiotherapy or had an exploratory lymph dissection and, therefore, had likely been treatment candidates.